These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 16007207
1. Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway. Pavio N, Battaglia S, Boucreux D, Arnulf B, Sobesky R, Hermine O, Brechot C. Oncogene; 2005 Sep 08; 24(40):6119-32. PubMed ID: 16007207 [Abstract] [Full Text] [Related]
2. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation. Cheng PL, Chang MH, Chao CH, Lee YH. Oncogene; 2004 Oct 14; 23(47):7821-38. PubMed ID: 15334054 [Abstract] [Full Text] [Related]
3. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells. Sugano Y, Matsuzaki K, Tahashi Y, Furukawa F, Mori S, Yamagata H, Yoshida K, Matsushita M, Nishizawa M, Fujisawa J, Inoue K. Oncogene; 2003 Apr 17; 22(15):2309-21. PubMed ID: 12700666 [Abstract] [Full Text] [Related]
4. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K. Hepatology; 2009 Apr 17; 49(4):1203-17. PubMed ID: 19263472 [Abstract] [Full Text] [Related]
5. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. Taniguchi H, Kato N, Otsuka M, Goto T, Yoshida H, Shiratori Y, Omata M. J Med Virol; 2004 Jan 17; 72(1):52-9. PubMed ID: 14635011 [Abstract] [Full Text] [Related]
6. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction. Kuang C, Chen Y. Oncogene; 2004 Feb 05; 23(5):1021-9. PubMed ID: 14647410 [Abstract] [Full Text] [Related]
7. Viral hepatitis and liver cancer: the case of hepatitis C. Levrero M. Oncogene; 2006 Jun 26; 25(27):3834-47. PubMed ID: 16799625 [Abstract] [Full Text] [Related]
8. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells. Mithani SK, Balch GC, Shiou SR, Whitehead RH, Datta PK, Beauchamp RD. J Surg Res; 2004 Apr 26; 117(2):296-305. PubMed ID: 15047135 [Abstract] [Full Text] [Related]
9. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis. Choi SH, Jeong SH, Hwang SB. Gastroenterology; 2007 Jan 26; 132(1):343-57. PubMed ID: 17241884 [Abstract] [Full Text] [Related]
10. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling. Imoto S, Sugiyama K, Sekine Y, Matsuda T. FEBS Lett; 2005 May 23; 579(13):2853-62. PubMed ID: 15907489 [Abstract] [Full Text] [Related]
11. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP. Cui Q, Lim SK, Zhao B, Hoffmann FM. Oncogene; 2005 Jun 02; 24(24):3864-74. PubMed ID: 15750622 [Abstract] [Full Text] [Related]
12. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Kato N, Yoshida H, Ono-Nita SK, Kato J, Goto T, Otsuka M, Lan K, Matsushima K, Shiratori Y, Omata M. Hepatology; 2000 Aug 02; 32(2):405-12. PubMed ID: 10915750 [Abstract] [Full Text] [Related]
13. [Construction and expression of plasmids containing different truncated core proteins of hepatitis C virus derived from tumor and non-tumor tissues]. Yan XB, Chen Z, Delphine B, Nicole P, Christian B. Zhonghua Gan Zang Bing Za Zhi; 2004 Nov 02; 12(11):643-7. PubMed ID: 15623368 [Abstract] [Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling. Seo T, Park J, Choe J. Cancer Res; 2005 Mar 01; 65(5):1738-47. PubMed ID: 15753369 [Abstract] [Full Text] [Related]
15. Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Yakicier MC, Irmak MB, Romano A, Kew M, Ozturk M. Oncogene; 1999 Aug 26; 18(34):4879-83. PubMed ID: 10490821 [Abstract] [Full Text] [Related]
16. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. Koike K. J Gastroenterol Hepatol; 2007 Jun 26; 22 Suppl 1():S108-11. PubMed ID: 17567457 [Abstract] [Full Text] [Related]
17. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. Nat Med; 1998 Sep 26; 4(9):1065-7. PubMed ID: 9734402 [Abstract] [Full Text] [Related]
18. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta. Park YN, Chae KJ, Oh BK, Choi J, Choi KS, Park C. Hepatogastroenterology; 2004 Sep 26; 51(56):396-400. PubMed ID: 15086168 [Abstract] [Full Text] [Related]
19. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury. Kobayashi K, Yokote K, Fujimoto M, Yamashita K, Sakamoto A, Kitahara M, Kawamura H, Maezawa Y, Asaumi S, Tokuhisa T, Mori S, Saito Y. Circ Res; 2005 Apr 29; 96(8):904-12. PubMed ID: 15790953 [Abstract] [Full Text] [Related]
20. Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Rüster B, Zeuzem S, Roth WK. Biochem Biophys Res Commun; 1996 Feb 27; 219(3):911-5. PubMed ID: 8645278 [Abstract] [Full Text] [Related] Page: [Next] [New Search]